ArticlemedRxiv : the preprint server for health sciences2026
Plasma pTau217 as a Prognostic, Monitoring, and Risk-Stratification Biomarker of Clinical Progression in Lewy Body Disease.
S A Lorkiewicz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.